Jeronimo
Martinez Garcia
Asociado Ciencias de la Salud
Oslo University Hospital
Oslo, NoruegaOslo University Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2024
-
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
The Lancet, Vol. 403, Núm. 10421, pp. 31-43